Spots Global Cancer Trial Database for stage iv ovarian epithelial cancer

Every month we try and update this database with for stage iv ovarian epithelial cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors	NCT00471432	Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu...	custirsen sodiu... docetaxel pharmacological...	18 Years - 120 Years	Canadian Cancer Trials Group
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors	NCT00006036	Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	cisplatin lurtotecan lipo...	18 Years - 120 Years	Canadian Cancer Trials Group
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00964626	Ovarian Cancer	cisplatin paclitaxel	18 Years - 72 Years	National Cancer Institute (NCI)
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer	NCT00112957	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	rV-NY-ESO-1 vac... rF-NY-ESO-1 vac...	18 Years -	Ludwig Institute for Cancer Research
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	NCT02122185	Brenner Tumor Malignant Ascit... Malignant Pleur... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Serous ... Ovarian Undiffe... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar...	metformin hydro... placebo Chemotherapy	18 Years -	University of Chicago
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma	NCT00390234	Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo...	ziv-aflibercept	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	NCT00550784	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	filgrastim cisplatin cyclophosphamid... melphalan paclitaxel topotecan hydro... TdT-mediated dU... gene expression... immunohistochem... pharmacological... peripheral bloo...	- 60 Years	City of Hope Medical Center
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer	NCT00337233	Breast Cancer Fatigue Ovarian Cancer Psychosocial Ef...	yoga therapy	18 Years - 120 Years	Wake Forest University Health Sciences
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer	NCT00003385	Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin paclitaxel pegylated lipos...	-	GOG Foundation
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery	NCT02013492	Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ...	propranolol hyd... Correlative Stu...	18 Years -	Ohio State University Comprehensive Cancer Center
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission	NCT00522301	Fallopian Tube ... Ovarian Cancer Primary Periton...	sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission	NCT00522301	Fallopian Tube ... Ovarian Cancer Primary Periton...	sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors	NCT01233505	Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu...	veliparib capecitabine oxaliplatin pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer	NCT00010179	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	lurtotecan lipo...	18 Years - 120 Years	Canadian Cancer Trials Group
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer	NCT00003670	Ovarian Cancer Primary Periton...	arzoxifene hydr...	18 Years -	Eli Lilly and Company
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer	NCT00093496	Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria...	gemcitabine hyd... tanespimycin	18 Years -	National Cancer Institute (NCI)
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00825201	Ovarian Cancer Peritoneal Cavi... Unspecified Adu...	paclitaxel albu... liquid chromato... mass spectromet... pharmacological... laboratory biom...	19 Years -	City of Hope Medical Center
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer	NCT00004064	Fallopian Tube ... Ovarian Cancer Primary Periton...	oregovomab	18 Years -	National Cancer Institute (NCI)
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers	NCT00684801	Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	questionnaire a... quality-of-life...	18 Years -	Case Comprehensive Cancer Center
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00041080	Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria...	tamoxifen citra... thalidomide laboratory biom...	-	National Cancer Institute (NCI)
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	NCT00004895	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine...	octreotide acet...	18 Years -	Northwestern University
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer	NCT00003080	Ovarian Cancer	endocrine-modul... melphalan mitoxantrone hy... tamoxifen citra... thiotepa peripheral bloo...	18 Years - 60 Years	Fred Hutchinson Cancer Center
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer	NCT00003072	Lung Cancer Neurotoxicity Ovarian Cancer	amifostine trih... carboplatin paclitaxel	18 Years -	University of California, San Francisco
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer	NCT00004064	Fallopian Tube ... Ovarian Cancer Primary Periton...	oregovomab	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	NCT01126346	Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi...	HIPEC Orientati... Consultation wi... Questionnaires	-	Wake Forest University Health Sciences
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer	NCT00002671	Ovarian Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer	NCT00022659	Primary Periton... Recurrent Ovari... Stage IV Ovaria...	bevacizumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Quality-of-Life Assessment in Patients With Ovarian Cancer	NCT00003772	Ovarian Cancer	quality-of-life...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Quality-of-Life Assessment in Patients With Ovarian Cancer	NCT00003772	Ovarian Cancer	quality-of-life...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer	NCT00217529	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	pegfilgrastim carboplatin docetaxel erlotinib hydro...	18 Years -	Fred Hutchinson Cancer Center
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	NCT01126346	Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi...	HIPEC Orientati... Consultation wi... Questionnaires	-	Wake Forest University Health Sciences
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)	NCT00562640	Fallopian Tube ... Ovarian Cancer Primary Periton...	filgrastim therapeutic aut... cyclophosphamid... laboratory biom...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00006454	Fallopian Tube ... Ovarian Cancer	carboplatin paclitaxel topotecan hydro...	18 Years - 120 Years	AGO Study Group
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	NCT00063895	Recurrent Non-s... Recurrent Ovari... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Non-sm... Stage IV Ovaria... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam...	erlotinib hydro... pharmacological... pharmacogenomic... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer	NCT00253708	Cancer	management of t... massage therapy pain therapy psychosocial as... quality-of-life...	18 Years - 120 Years	Beth Israel Deaconess Medical Center
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy	NCT00003634	Fallopian Tube ... Ovarian Cancer Primary Periton...	oregovomab	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer	NCT00005051	Ovarian Cancer	carboplatin cisplatin paclitaxel topotecan hydro...	18 Years -	NYU Langone Health
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer	NCT00043082	Ovarian Cancer Peritoneal Cavi...	carboplatin pegylated lipos...	18 Years - 120 Years	SWOG Cancer Research Network
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	NCT00089362	Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas...	alvespimycin hy... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer	NCT00005807	Breast Cancer Ovarian Cancer Unspecified Adu...	BMS-247550	18 Years - 120 Years	Albert Einstein College of Medicine
Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer	NCT00002671	Ovarian Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer	NCT00003297	Ovarian Cancer	mitoxantrone hy... thiotepa topotecan hydro... peripheral bloo...	18 Years -	Georgetown University
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission	NCT00003120	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	paclitaxel	18 Years -	SWOG Cancer Research Network
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors	NCT00433407	Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu...	trastuzumab	-	Jonsson Comprehensive Cancer Center
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer	NCT01927393	Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Stage III Pancr... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre...	palliative care educational int... quality-of-life... questionnaire a... telephone-based...	21 Years -	City of Hope Medical Center
3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer	NCT00081276	Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria...	triapine cisplatin laboratory biom...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors	NCT00004082	Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin docetaxel gemcitabine hyd...	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer	NCT00019084	Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum...	18 Years -	National Cancer Institute (NCI)
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer	NCT00085527	Ovarian Cancer	depsipeptide	18 Years -	University of Chicago
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors	NCT00526149	Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma	BI 2536 high performanc... mass spectromet... pharmacological...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies	NCT00335998	Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological...	18 Years -	National Cancer Institute (NCI)
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00041080	Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria...	tamoxifen citra... thalidomide laboratory biom...	-	National Cancer Institute (NCI)
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer	NCT00006230	Ovarian Cancer	rubitecan	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer	NCT00006267	Ovarian Cancer Primary Periton...	rubitecan	-	GOG Foundation
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission	NCT00522301	Fallopian Tube ... Ovarian Cancer Primary Periton...	sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer	NCT00031954	Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin gemcitabine hyd... paclitaxel	18 Years - 120 Years	AGO Study Group
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	NCT01126346	Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi...	HIPEC Orientati... Consultation wi... Questionnaires	-	Wake Forest University Health Sciences
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer	NCT00382811	Fallopian Tube ... Peritoneal Neop... Ovarian Cancer	phenoxodiol carboplatin placebo	18 Years -	MEI Pharma, Inc.
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer	NCT00030706	Ovarian Cancer Peritoneal Cavi...	ixabepilone	18 Years - 75 Years	Montefiore Medical Center
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer	NCT00436410	Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma	colloidal gold-... electron micros... pharmacological... conventional su...	18 Years -	National Institutes of Health Clinical Center (CC)
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00964626	Ovarian Cancer	cisplatin paclitaxel	18 Years - 72 Years	National Cancer Institute (NCI)
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer	NCT00003670	Ovarian Cancer Primary Periton...	arzoxifene hydr...	18 Years -	Eli Lilly and Company
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00748527	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	carboplatin decitabine	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: